Healthy Clinical Trial
Official title:
A Mass Balance Study to Investigate the Absorption, Metabolism, Excretion of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371- Microtracer Dose in Healthy Male Subjects
The primary objectives of the study are:
• To assess the absorption, metabolism, excretion of LCB01-0371 after a single oral
LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose to healthy subjects
This is a single-center, open-label, non-randomized, one-sequence, one-period, single arm study in healthy male subjects. A total of 6 subjects will be enrolled in the study, and a minimum of 4 evaluable subjects are considered sufficient. An evaluable subject is defined as a subject who has provided whole blood, plasma, exhalation and excreta samples sufficient for evaluation of the primary objectives. Study subjects will be screened for eligibility to participate in the study within 28 days before dosing. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT00001844 -
Study of New Magnetic Resonance Methods
|
||
| Completed |
NCT03160261 -
Effect of Exenatide on Cortisol Secretion
|
Phase 4 | |
| Completed |
NCT03662100 -
A Study of Two Formulations of LY3074828 in Healthy Participants
|
Phase 1 | |
| Recruiting |
NCT02875301 -
Investigating Gains in Neurocognition in an Intervention Trial of Exercise
|
Phase 3 | |
| Completed |
NCT03656952 -
A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03670082 -
Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State
|
Phase 1 | |
| Completed |
NCT03056846 -
Probiotics on Stress-associated Gastrointestinal Function in University Students
|
N/A | |
| Completed |
NCT03203824 -
The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals
|
N/A | |
| Recruiting |
NCT03114839 -
Effect of Lactobacillus Casei Shirota on the Small Intestinal Microbiota (ROBIN)
|
N/A | |
| Completed |
NCT03224702 -
First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03259464 -
This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated
|
Phase 1 | |
| Completed |
NCT03309566 -
Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir
|
Phase 4 | |
| Completed |
NCT00527579 -
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB
|
Phase 1 | |
| Completed |
NCT00526916 -
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28
|
Phase 1 | |
| Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
| Completed |
NCT03373162 -
Functional Effects of Botox on the Brain Using MRS and fMRI
|
Phase 4 | |
| Active, not recruiting |
NCT02509494 -
Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2
|
Phase 3 | |
| Terminated |
NCT02555085 -
Single Ascending Doses of BIIB063 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03125018 -
Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX)
|
N/A |
